Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-12

Clinical Trial Update: Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)

View source ↗

Summary

This clinical trial update describes a real-world evidence study evaluating the use of faricimab in diabetic macular edema, neovascular age-related macular dege…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Faricimab (faricimab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetic Macular Edema, Neovascular Age-related Macular Degeneration | Status: RECRUITING